Prime Editing Unlocks a Universal Strategy for Restoring Lost Proteins
November 22, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Megalac almasilate
Synonyms :
almasilate, Almasilato, Almasilatum, Magnesium aluminoslicate hydrate
Class :
Gastrointestinal Agent, Agents for peptic ulcer, Antacid
Brand Name :
Megalac almasilate
Synonyms :
almasilate, Almasilato, Almasilatum, Magnesium aluminoslicate hydrate
Class :
Gastrointestinal Agent, Agents for peptic ulcer, Antacid
Dosage Forms & StrengthsÂ
SuspensionÂ
10 mLÂ
250 mLÂ
Neutralizing excess acid in the stomach needs an antacid. almasilate is an antacid used to treat heart burns and stomach and duodenal ulcers caused by excess acid inside the stomach. almasilate is used for the symptomatic treatment
Two teaspoons of almasilate, which is equivalent to 10 mL, is recommended daily four times
Dose Adjustments
Limited data is available
Safety and efficacy are not seen in pediatricsÂ
Refer to the adult dosingÂ
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids May decrease the bioavailability of corticosteroids
antacids may reduce the absorption of quinolones
antacids may reduce the absorption of quinolones
bismuth subcitrate, metronidazole and tetracycline
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids may decrease the absorption of tetracyclines
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the serum concentration of calcium salts
antacids: they may diminish the serum concentration of calcium salts
antacids: they may diminish the serum concentration of calcium salts
antacids: they may diminish the serum concentration of calcium salts
antacids: they may diminish the serum concentration of calcium salts
antacids: they may diminish the bioavailability of corticosteroids K1
antacids: they may diminish the bioavailability of corticosteroids K1
may diminish the absorption when combined with phosphate supplements
may diminish the absorption when combined with phosphate supplements
may diminish the absorption when combined with phosphate supplements
may diminish the absorption when combined with phosphate supplements
may diminish the absorption when combined with phosphate supplements
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may diminish the effect of each other when combined
may reduce the level of serum concentration of acalabrutinib
may diminish the bioavailability of corticosteroids
may diminish the serum concentration
may diminish the quinolones absorption
may diminish the absorption of iron preparations
may diminish the bioavailability of corticosteroids
may diminish the absorption of quinolones
may diminish the therapeutic effect when combined with lanthanum
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may diminish the serum concentration when combined with fosinopril
may diminish the serum concentration when combined
atazanavir: they may diminish the absorption of antacids
belumosudil: they may diminish the serum concentration of antacids
bisacodyl: they may decrease the therapeutic effect of antacids
bismuth subnitrate: they may decrease the therapeutic effect of antacids
bosutinib: they may diminish the serum concentration of antacids
antacids: they may diminish the serum concentration of dasatinib
delavirdine: they may diminish the serum concentration of antacids
erlotinib: they may diminish the serum concentration of antacids
gefitinib: they may diminish the serum concentration of antacids
hyoscyamine: they may diminish the serum concentration of antacids
infigratinib: they may diminish serum concentrations of antacids
itraconazole: they may diminish the serum concentration of antacids
ketoconazole: they may diminish the serum concentration of antacids
levoketoconazole: they may diminish the absorption of antacids
mesalamine: they may decrease the therapeutic effect of antacids
methenamine: they may decrease the therapeutic effect of antacids
neratinib: they may diminish the serum concentration of antacids
nilotinib: they may diminish the serum concentration of antacids
pazopanib: they may diminish the serum concentration of antacids
pexidartinib: they may diminish the serum concentration of antacids
riociguat: they may diminish the serum concentration of antacids
selpercatinib: they may diminish the serum concentration of antacids
sotalol: they may diminish the serum concentration of antacids
sotorasib: they may diminish the serum concentration of antacids
sparsentan: they may diminish the serum concentration of antacids
sulpiride: they may diminish the serum concentration of antacids
velpatasvir: they may diminish the serum concentration of antacids
ciprofloxacin inhaled (Pending FDA approval)Â
may diminish the absorption of Quinolones
potassium phosphate: they may diminish the serum concentration of antacids
Alpha-Lipoic Acid: they may diminish the absorption of antacids
bisacodyl rectal: they may decrease the therapeutic effect of antacids
bictegravir: they may decrease the therapeutic effect of antacids
cefdinir: they may diminish the absorption of antacids
chloroquine: they may diminish the serum concentration of antacids
deferiprone: they may diminish the serum concentration of antacids
elvitegravir: they may diminish the serum concentration of antacids
tetracyclins: they may diminish the serum concentration of antacids
may decrease the therapeutic effect of each other when combined
antacids decrease the concentration of cefditoren in serum
antacids decrease the systemic absorption of naproxen
they decrease the absorption of naproxen
they decrease the concentration of rilpivirine in the serum
cefditoren: they may diminish the serum concentration of antacids
misoprostol: they may increase the toxic effect of antacids
may decrease the effects of the drug by GI absorption inhibition
may decrease the effects of the drug by GI absorption inhibition
may decrease the effects of the drug by GI absorption inhibition
may decrease the effects of the drug by GI absorption inhibition
may decrease the effects of the drug by GI absorption inhibition
antacids may decrease the absorption of quinolones
antacids may decrease the absorption of quinolones
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may decrease the excretion of amphetamines
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the serum concentration of minerals
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may reduce the bioavailability of corticosteroids
may decrease the absorption of iron preparations
may decrease the absorption of iron preparations
may decrease the absorption of iron preparations
may decrease the absorption of iron preparations
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the bioavailability
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
may decrease the serum concentration
antacids: they may enhance the serum concentration of thyroid products
antacids: they may enhance the serum concentration of thyroid products
antacids: they may enhance the serum concentration of thyroid products
antacids: they may enhance the serum concentration of thyroid products
they decrease the absorption of antipsychotic agents
they decrease the absorption of antipsychotic agents
they decrease the absorption of antipsychotic agents
they decrease the absorption of antipsychotic agents
they decrease the absorption of antipsychotic agents
tinidazole has the potential to reduce the rate of excretion of almasilate, potentially leading to an elevation in level of serum
cefpirome leads to a reduction in the rate of excretion of almasilate which leads to increased level of serum
almasilate leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
almasilate leads to a reduction in the rate of excretion of potassium acetate, which leads to an increased level of serum
almasilate: it may decrease the excretion rate of isepamicin
carbaspirin calcium may reduce the excretion rate of almasilate, possibly resulting in an elevated serum level
giving clonixin a shot may slow down the drug's excretion rate, which could lead to higher serum concentrations
tepoxalin may reduce the excretion rate of almasilate, potentially resulting in increased serum levels
may enhance the absorption of each other when combined
may enhance the absorption of each other when combined
chromic nitrate may decrease the excretion rate of almasilate, leading to higher serum levels
chromic chloride may decrease the excretion rate of almasilate, leading to higher serum levels
chondroitin sulfate may decrease the excretion rate of almasilate, leading to higher serum levels
choline salicylate may decrease the excretion rate of almasilate, leading to higher serum levels
choline magnesium trisalicylateÂ
choline magnesium trisalicylate may decrease the excretion rate of almasilate, leading to higher serum levels
it may decrease the excretion of amphetamines 
antacids reduce the systemic absorption of bromeperidol
antacids reduce the concentration of captopril in serum
antacids reduces the systemic absorption of diacerein
antacids reduce the systemic absorption of isoniazid
antacids reduce the concentration of octreotide in the serum
antacids reduce the excretion of quinidine
antacids reduce the concentration of rosuvastatin in the serum
may decrease the absorption of iron preparations
may decrease the absorption of iron preparations
may decrease the absorption of iron preparations
may diminish the excretion of amphetamines
antacids decrease the efficacy of cysteamine
may decrease the serum concentration
may decrease the serum concentration
may decrease the serum concentration
tetraferric tricitrate decahydrate
may decrease the serum concentration
may decrease the serum concentration
bromeperidol: they may decrease the absorption of antacids:
captopril: they may diminish the serum concentration of antacids
octreotide: they may diminish the serum concentration of antacids
rosuvastatin: they may diminish the serum concentration of antacids
antacids can reduce the absorption of diacerein
calcium polystyrene sulfonateÂ
calcium polystyrene sulfonate: they may increase the toxic effect of antacids
cefpodoxime: they may diminish the serum concentration of antacids
isoniazid: they may diminish the absorption of antacids
ledipasvir: they may diminish the serum concentration of antacids
an increase in serum level with a decreased excretion rate of almasilate is observed when used in combination with abacavir
an increase in serum level with a decreased excretion rate of almasilate is observed when used in combination with aceclofenac
an increase in serum level with a decreased excretion rate of almasilate is observed when used in combination with tramadol
an increase in serum level with a decreased excretion rate of almasilate is observed when used in combination with benzatropine
there is a decrease in absorption of bifonazole, which is seen with decreased serum concentration and also in its reduced efficacy when used in combination with almasilate
dried ferrous sulfate/folic acidÂ
reduces the gastrointestinal absorption of iron
the absorption of ferrous bisglycinate may be diminished by almasilate, resulting in a lowered serum concentration and potential compromise in efficacy
almasilate may inhibit the absorption of ferrous succinate, resulting in a drop in serum levels and possible reduction in efficacy
the rate of excretion of almasilate may be reduced
the rate of excretion of almasilate may be reduced
proquazone may decrease the rate at which almasilate is excreted, which could raise the serum level of the drug
flunixin may lower the excretion rate of almasilate which could result in a raised serum level
niflumic acid may lower the excretion rate of almasilate, which could result in a raised serum level
etoricoxib: it may decrease the excretion rate of almasilate
choline c 11 may decrease the excretion rate of almasilate, leading to higher serum levels
chlorzoxazone may decrease the excretion rate of almasilate, leading to higher serum levels
chlorthalidone may increase the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
chlorpropamide may decrease the excretion rate of almasilate, leading to higher serum levels
chlorpromazine's absorption may be reduced by almasilate, resulting in lower serum concentrations and potentially decreased efficacy
chlorothiazide may increase the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
chloroquine's absorption may be reduced by almasilate, resulting in lower serum concentrations and potentially decreased efficacy
chloral hydrate may decrease the excretion rate of almasilate, leading to higher serum levels
cevimeline may decrease the excretion rate of almasilate, leading to higher serum levels
cetirizine may decrease the excretion rate of almasilate, leading to higher serum levels
certolizumab pegol may decrease the excretion rate of almasilate, leading to higher serum levels
cephaloglycin may decrease the excretion rate of almasilate, leading to higher serum levels
cephalexin may decrease the excretion rate of almasilate, leading to higher serum levels
celecoxib may decrease the excretion rate of almasilate, leading to higher serum levels
cefuroxime's serum concentration may be reduced when it is combined with almasilate
ceftriaxone may decrease the excretion rate of almasilate, leading to higher serum levels
ceftolozane may decrease the excretion rate of almasilate, leading to higher serum levels
ceftobiprole may decrease the excretion rate of almasilate, leading to higher serum levels
ceftizoxime may decrease the excretion rate of almasilate, leading to higher serum levels
ceftibuten may decrease the excretion rate of almasilate, leading to higher serum levels
ceftazidime may decrease the excretion rate of almasilate, leading to higher serum levels
ceftaroline may decrease the excretion rate of almasilate, leading to higher serum levels
cefradine may decrease the excretion rate of almasilate, leading to higher serum levels
cefprozil may decrease the excretion rate of almasilate, leading to higher serum levels
cefpodoxime's serum concentration may be reduced when it is combined with almasilate
cefpirome may decrease the excretion rate of almasilate, leading to higher serum levels
cefoxitin may decrease the excretion rate of almasilate, leading to higher serum levels
cefotiam may decrease the excretion rate of almasilate, leading to higher serum levels
cefotetan may decrease the excretion rate of almasilate, leading to higher serum levels
cefotaxime may decrease the excretion rate of almasilate, leading to higher serum levels
ceforanide may decrease the excretion rate of almasilate, leading to higher serum levels
cefoperazone may decrease the excretion rate of almasilate, leading to higher serum levels
cefonicid may decrease the excretion rate of almasilate, leading to higher serum levels
cefmetazole may decrease the excretion rate of almasilate, leading to higher serum levels
cefmenoxime may decrease the excretion rate of almasilate, leading to higher serum levels
cefepime may decrease the excretion rate of almasilate, leading to higher serum levels
cefditoren's serum concentration may be reduced when it is combined with almasilate
cefdinir's therapeutic efficacy may be reduced when used in combination with almasilate
cefazolin may decrease the excretion rate of almasilate, leading to higher serum levels
cefapirin may decrease the excretion rate of almasilate, leading to higher serum levels
cefamandole may decrease the excretion rate of almasilate, leading to higher serum levels
cefalotin may decrease the excretion rate of almasilate, leading to higher serum levels
cefadroxil may decrease the excretion rate of almasilate, leading to higher serum levels
cefaclor may decrease the excretion rate of almasilate, leading to higher serum levels
carprofen may decrease the excretion rate of almasilate, leading to higher serum levels
carmustine may decrease the excretion rate of almasilate, leading to higher serum levels
carboplatin may decrease the excretion rate of almasilate, leading to higher serum levels
carbidopa may decrease the excretion rate of almasilate, leading to higher serum levels
carbamazepine may decrease the excretion rate of almasilate, leading to higher serum levels
captopril's absorption may be reduced by almasilate, resulting in lower serum concentrations and potentially decreased efficacy
capreomycin's excretion rate may be lowered by almasilate, resulting in increased serum levels
capecitabine may decrease the excretion rate of almasilate, leading to higher serum levels
canrenoic acid may increase the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
canagliflozin may decrease the excretion rate of almasilate, leading to higher serum levels
butabarbital may decrease the excretion rate of almasilate, leading to higher serum levels
buspirone may decrease the excretion rate of almasilate, leading to higher serum levels
bupropion may decrease the excretion rate of almasilate, leading to higher serum levels
bumetanide may increase the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
bumadizone may decrease the excretion rate of almasilate, leading to higher serum levels
budesonide's bioavailability may be reduced when combined with almasilate
bromotheophylline may increase the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
bromazepam may decrease the excretion rate of almasilate, leading to higher serum levels
brivaracetam may decrease the excretion rate of almasilate, leading to higher serum levels
bosutinib's absorption may be reduced by almasilate, resulting in lower serum concentrations and potentially decreased efficacy
bleomycin may decrease the excretion rate of almasilate, leading to higher serum levels
bisoxatin may decrease the excretion rate of almasilate, leading to higher serum levels
bisoprolol may decrease the excretion rate of almasilate, leading to higher serum levels
bismuth subgallate may decrease the excretion rate of almasilate, leading to higher serum levels
bisacodyl's therapeutic efficacy may be reduced when used in combination with almasilate
bicisate may decrease the excretion rate of almasilate, leading to higher serum levels
betamethasone's bioavailability may be reduced when combined with almasilate
bepotastine may decrease the excretion rate of almasilate, leading to higher serum levels
benzydamine may decrease the excretion rate of almasilate, leading to higher serum levels
benzthiazide may increase the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
benzphetamine's serum concentration may increase when combined with almasilate
benznidazole may decrease the excretion rate of almasilate, leading to higher serum levels
benserazide may decrease the excretion rate of almasilate, leading to higher serum levels
benoxaprofen may decrease the excretion rate of almasilate, leading to higher serum levels
benorilate may decrease the excretion rate of almasilate, leading to higher serum levels
bendroflumethiazide may increase the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
beclomethasone dipropionate's bioavailability may be reduced when combined with almasilate
baricitinib may decrease the excretion rate of almasilate, leading to higher serum levels
balsalazide may decrease the excretion rate of almasilate, leading to higher serum levels
baclofen may decrease the excretion rate of almasilate, leading to higher serum levels
bacitracin may decrease the excretion rate of almasilate, leading to higher serum levels
amantadine may reduce the elimination rate of almasilate, potentially leading to elevated serum levels
amikacin's excretion rate may be lowered by almasilate, resulting in increased serum levels
amiloride may enhance the excretion rate of almasilate, potentially lowering serum levels and reducing efficacy
aminophenazone may decrease the excretion rate of almasilate, leading to higher serum levels
amitriptyline may decrease the excretion rate of almasilate, potentially increasing serum levels
ammonium chloride may decrease the excretion rate of almasilate, resulting in higher serum levels
amoxicillin may decrease the excretion rate of almasilate, leading to higher serum levels
amphetamine's serum concentration may increase when combined with almasilate
amphotericin b may decrease the excretion rate of almasilate, leading to higher serum levels
ampicillin may decrease the excretion rate of almasilate, leading to higher serum levels
amprenavir's absorption may be reduced by almasilate, resulting in lower serum concentrations and potentially decreased efficacy
amrinone may decrease the excretion rate of almasilate, leading to higher serum levels
ancestim may decrease the excretion rate of almasilate, leading to higher serum levels
antihemophilic factor recombinantÂ
antihemophilic factor (recombinant), pegylated may decrease the excretion rate of almasilate, leading to higher serum levels
antipyrine may decrease the excretion rate of almasilate, leading to higher serum levels
antithrombin iii human may decrease the excretion rate of almasilate, leading to higher serum levels
antrafenine may decrease the excretion rate of almasilate, leading to higher serum levels
apalutamide may decrease the excretion rate of almasilate, leading to higher serum levels
apremilast may decrease the excretion rate of almasilate, leading to higher serum levels
arformoterol may decrease the excretion rate of almasilate, leading to higher serum levels
arsenic trioxide may decrease the excretion rate of almasilate, leading to higher serum levels
asunaprevir's absorption may be reduced by almasilate, resulting in lower serum concentrations and potentially decreased efficacy
atazanavir's absorption may be reduced by almasilate, resulting in lower serum concentrations and potentially decreased efficacy
atomoxetine may decrease the excretion rate of almasilate, leading to higher serum levels
auranofin may decrease the excretion rate of almasilate, leading to higher serum levels
aurothioglucose may decrease the excretion rate of almasilate, leading to higher serum levels
azacitidine may decrease the excretion rate of almasilate, leading to higher serum levels
azathioprine may decrease the excretion rate of almasilate, leading to higher serum levels
azelaic acid may decrease the excretion rate of almasilate, leading to higher serum levels
aztreonam may decrease the excretion rate of almasilate, leading to higher serum levels
Actions and Spectrum:Â
Actions:Â
Neutralizing excess acid in the stomach needs an antacid. almasilate is an antacid used to treat heart burns and stomach and duodenal ulcers caused by excess acid inside the stomach. almasilate is used for the symptomatic treatment.  Â
Spectrum:Â
The spectrum of activity of almasilate is indicated for peptic ulcer, heartburn, indigestion, GERD, Gastric Hypersecretory Conditions.Â
Frequency not defined Â
Mushy stoolsÂ
Hypersensitivity reactionsÂ
Silicate stones in kidneys and gall bladderÂ
FlatulenceÂ
BloatingÂ
Black Box Warning:Â
Do not use almasilate if you are allergic and if your blood phosphate levels are low.Â
Contraindication/Caution:Â
ContraindicationsÂ
CautionsÂ
Pregnancy consideration:Â Â
No data is available regarding the administration of the drug during pregnancy.Â
Breastfeeding warnings:Â Â
No data is available regarding the excretion of drug in breast milk.Â
Pregnancy category:Â
Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: No data is available for the drug under this category.Â
Pharmacology:Â
Neutralizing excess acid in the stomach needs an antacid. almasilate is an antacid used to treat heart burns and stomach and duodenal ulcers caused by excess acid inside the stomach. almasilate is used for the symptomatic treatment.Â
Pharmacodynamics:Â
Neutralizing excess acid in the stomach needs an antacid. almasilate is an antacid used to treat heart burns and stomach and duodenal ulcers caused by excess acid inside the stomach. almasilate is used for the symptomatic treatment.Â
Pharmacokinetics:Â
AbsorptionÂ
The bioavailability is 0.01-1%Â
DistributionÂ
Protein-bound is 60% to transferrin protein and 34% to albumin protein.Â
The volume of distribution of betrixaban is 0.250-0.442 L/kgÂ
MetabolismÂ
Limited data is available.Â
Elimination and ExcretionÂ
The drug is excreted in the form of magnesium 95% in urine.Â
Administration:Â
Neutralizing excess acid in the stomach needs an antacid. almasilate is an antacid used to treat heart burns and stomach and duodenal ulcers caused by excess acid inside the stomach.
almasilate is used for the symptomatic treatment. Two teaspoons of almasilate, which is equivalent to 10 mL, is recommended daily four times for a duration of 2 weeks.Â
Patient information leafletÂ
Generic Name: almasilateÂ
Pronounced: AL-muh-si-lateÂ
Why do we use almasilate?Â
Neutralizing excess acid in the stomach needs an antacid. almasilate is an antacid used to treat heart burns and stomach and duodenal ulcers caused by excess acid inside the stomach. almasilate is used for the symptomatic treatment.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
